Related Experiment Videos
Correlation of serum prostate specific antigen and semi quantitative tissue RT-PCR from prostate cancer samples
M Colombel1, J M Marechal, A Gelet
1Hopital Edouard Herriot, Poitiers, France.
Prostate Cancer and Prostatic Diseases
|December 24, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Transrectal high-intensity focused ultrasound (HIFU) for management of rectosigmoid deep infiltrating endometriosis: results of Phase-I clinical trial.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
[Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
Diagnostic and interventional imaging·2016
[Management of rectourethral fistulas with the York Mason procedure: surgical techniques and outcomes].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2014
[Treatment of stress urinary incontinence after prostate surgery: results of the artificial urinary sphincter after suburethral sling failure].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2012
Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy.
Prostate cancer and prostatic diseases·2026
Prostate size and its effect on sexual function following convective water vapor thermal therapy.
Prostate cancer and prostatic diseases·2026
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report.
Prostate cancer and prostatic diseases·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer.
Prostate cancer and prostatic diseases·2026